Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas-Reference-Cited by-同舟云学术

Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas

Published:2016-10 Issue:15 Volume:49 Page:1205-1208
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Patin Franck,Crinière Lise,Francia Thomas,Kassem Sandra,Pierre Peggy,Bruno Clément,Vayne Caroline,Vourc'h Patrick,Benz-de Bretagne Isabelle,Andres Christian R.,Blasco Hélène

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference15 articles.

1. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients;Erickson;J. Clin. Endocrinol. Metab. [Internet],2001

2. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005;Pacak;Nat. Clin. Pract. Endocrinol. Metab.,2007

3. Dopamine excess in patients with head and neck paragangliomas;Horst-Schrivers;Anticancer Res. [Internet],2010

4. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status;Eisenhofer;Eur. J. Cancer,2012

5. Laboratory evaluation of pheochromocytoma and paraganglioma;Eisenhofer;Clin. Chem. [Internet],2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents;Nature Reviews Endocrinology;2024-08-15

2. Biochemical Assessment of Pheochromocytoma and Paraganglioma;Endocrine Reviews;2023-03-30

3. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma;European Journal of Cancer;2022-07

4. Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma—Experiences From the GPOH-MET Registry;Frontiers in Endocrinology;2022-06-17

5. Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma;Annales d'Endocrinologie;2019-09